CARA a Biotech Pennys Stock with earnings coming LONG
CARA is here on a 15 minute chart. The earnings report is due March 4th. The price action is
already demonstrative of bullish momentum. CARA rose 60% this past week. It is still on sale
at 95% off its all time high. Spiking buying volume, and so an upgoing Price Vulme Trend and
squeeze release triggers on lower time frames all have CARA moving well prior to earnings.
I see this as a long trade setup quite well. The available option contract on a thin-chain
for strike 2.5 on March 15 added 20% on Friday. I will pass on any options contracts as the
thin volume is a higher-than-acceptable risk. I will be more than happy with another 60%
price rise in the upcoming week and it could be more.
already demonstrative of bullish momentum. CARA rose 60% this past week. It is still on sale
at 95% off its all time high. Spiking buying volume, and so an upgoing Price Vulme Trend and
squeeze release triggers on lower time frames all have CARA moving well prior to earnings.
I see this as a long trade setup quite well. The available option contract on a thin-chain
for strike 2.5 on March 15 added 20% on Friday. I will pass on any options contracts as the
thin volume is a higher-than-acceptable risk. I will be more than happy with another 60%
price rise in the upcoming week and it could be more.